Long-term safety of fully human anti-TNF adalimumab in worldwide rheumatoid arthritis clinical trials

被引：0
|
作者：
Schiff, MH
Burmester, GR
Pangan, AL
Kupper, H
Spencer-Green, G
Kent, JD
机构：
[1] Charite Univ Med, Berlin, Germany
[2] Abbott GmbH & Co KG, Ludwigshafen, Germany
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2005年 / 100卷 / 09期
关键词：
D O I：
10.14309/00000434-200509001-00801
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
801
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [1] Long-term safety of adalimumab (humira®) in worldwide rheumatoid arthritis clinical trials
    Schiff, MH
    Burmester, GR
    Pangan, A
    Kupper, H
    Spencer-Green, GT
    RHEUMATOLOGY, 2005, 44 : I70 - I71
  • [2] Long-term safety and efficacy of anti-TNF multivalent VHH antibodies ozoralizumab in patients with rheumatoid arthritis
    Tanaka, Yoshiya
    Miyazaki, Yusuke
    Kawanishi, Masafumi
    Yamasaki, Hironori
    Takeuchi, Tsutomu
    RMD OPEN, 2024, 10 (03):
  • [3] Long-term safety of infliximab (anti-TNFα antibody) in patients with rheumatoid arthritis:: Results of the attract trial
    Schaible, TF
    Braakman, T
    Marsters, P
    Harriman, G
    GASTROENTEROLOGY, 1999, 116 (04) : A813 - A813
  • [4] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Taylor, A.
    Nash, P.
    Hall, S.
    Jones, G.
    Youssef, P.
    Porter-Brown, B.
    Thompson, L.
    Genovese, M.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 14 - 14
  • [5] LONG-TERM SAFETY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS CLINICAL TRIALS
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    Van Vollenhoven, Ronald
    RHEUMATOLOGY, 2012, 51 : 75 - 76
  • [6] Long-Term Safety of Tocilizumab in Rheumatoid Arthritis Clinical Trials.
    Genovese, Mark C.
    Sebba, Anthony
    Rubbert-Roth, Andrea
    Scali, Juan
    Zilberstein, Moshe
    Thompson, Liz
    van Vollenhoven, Ronald F.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S866 - S866
  • [7] Safety of adalimumab in long-term treatment of patients with rheumatoid arthritis
    Schiff, M
    Burmester, GR
    Kent, J
    Pangan, A
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (03) : P203 - P203
  • [8] Summary of clinical trials in rheumatoid arthritis using infliximab, an anti-TNFα treatment
    Harriman, G
    Harper, LK
    Schaible, TF
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 61 - 64
  • [9] Long-term effect of anti-TNF treatment on atherosclerosis risk factors in rheumatoid arthritis patients
    Sayo, Yoshitaka
    Dobashi, Hiroaki
    Matsubara, Shur
    Tada, Satoshi
    Taminato, Tomohiko
    Ishiija, Toshihiko
    DIABETES, 2008, 57 : A601 - A601
  • [10] Long-term effect of anti-TNF treatment on atherosclerosis risk factors in rheumatoid arthritis patients
    Sayo, Y.
    Dobashi, H.
    Matsubara, S.
    Ishida, I.
    DIABETOLOGIA, 2008, 51 : S538 - S538
12345